Participating Centres
Participating Haemophilia treatment centres report adverse events directly to the EUHASS web application. (Restricted Access)
About EUHASS
EUHASS is a pharmacovigilance program to monitor the safety of treatments for people with inherited bleeding disorders in Europe. Haemophilia treatment centres report adverse events directly to the EUHASS website and regular surveillance reports are produced.